Skip to main content
. 2023 Aug 13;4(2):100384. doi: 10.1016/j.xops.2023.100384

Table 2.

Demographics, Comorbidities, and Ocular Symptoms and Signs in the Study Population

Demographics
 Age, years, mean ± SD (range) 61.78 ± 9.79 (32–91)
 Gender, male, n (%) 302 (92)
 Race, White, n (%) 145 (44)
 Black, n (%) 183 (56)
 Ethnicity, Hispanic, n (%) 70 (21)
Comorbidities
 Hypertension, n (%) 229 (70)
 Diabetes mellitus, n (%) 99 (30)
 Sleep apnea, n (%) 74 (22)
 Benign prostatic hypertrophy, n (%) 56 (17)
 Former smoker, n (%) 154 (47)
 Current smoker, n (%) 130 (40)
 Migraine, n (%) 45 (14)
 Depression symptoms, PHQ-9, mean ± SD (range) 9.38 ± 7.83 (0–27)
 PTSD symptoms, PCL-M, mean ± SD (range) 39.64 ± 19.34 (17–85)
Ocular symptoms, mean ± SD (range)
 DE symptoms assessed via DEQ5 11.24 ± 5.18 (0–22)
 DE symptoms assessed via OSDI 34.91 ± 24.35 (0–100)
 Ocular pain assessed via NRS average over past week 3.18 ± 2.63 (0–10)
 Ocular pain assessed via NRS worst over past week 4.08 ± 3.18 (0–10)
 Neuropathic ocular pain assessed via NPSI-Eye, total score 20.17 ± 21.41 (0–100)
 NPSI-Eye-Sub-Score (burning + wind sensitivity) 5.11 ± 5.42 (0–20)
DE signs, mean ± SD (range)
 Tear break up time, seconds 8.95 ± 4.45 (0–28)
 Corneal staining 2.05 ± 2.48 (0–14)
 Schirmer’s test, mm wetting at 5 min 12.98 ± 7.35 (0–41)
Corneal sensation, mean ± SD (range)
 Detection threshold, ml/min 86.23 ± 44.70 (10–410)
 Pain threshold, ml/min 229.05 ± 114.08 (10–410)

DE = dry eye; DEQ5 = Dry Eye Questionnaire 5; NPSI-Eye = Neuropathic Pain Symptom Inventory Modified for the Eye; NRS = Numerical Rating Scale; OSDI = Ocular Surface Disease Index; PCL-M = PTSD Checklist – Military Version; PHQ-9 = Patient Health Questionnaire 9; PTSD = posttraumatic stress disorder; SD = standard deviation.

More abnormal value between the 2 eyes for each patient was included in the analysis.

Corneal sensation taken from the right eye.